Please enable Javascript
Conferences
Expert Interviews
Roundtable
Mesothelioma
Non-Small Cell Lung Cancer
ALK+ NSCLC
EGFR+ NSCLC
EGFR+ NSCLC Learning Lab
Immunotherapy in NSCLC
KRAS+ NSCLC
Small Cell Lung Cancer
Menu
Jorge Nieva, MD
Articles by Jorge Nieva, MD
Bedside-to-Bench Research Uncovers How Steroids Impact Survival in Patients Undergoing Immune Checkpoint Inhibitor Therapy for NSCLC
Jorge Nieva, MD
Immunotherapy in NSCLC
|
July 18, 2025
Jorge Nieva, MD, explains new findings showing how steroids impact survival in patients undergoing ICI therapy.
View More
Should Immunotherapy Be Administered Earlier in the Day? Thoracic Oncologist Weighs in on New ASCO 2025 Data
Jorge Nieva, MD
ASCO 2025
|
June 30, 2025
Jorge Nieva, MD, discusses a recent study that evaluated the impact of circadian rhythms on the efficacy of immunotherapy.
View More
Dr. Nieva Shares Insights From Epidemiology of Young Lung Cancer Trial
Jorge Nieva, MD
WCLC 2024
|
February 24, 2025
A distributed clinical trial is analyzing diet and exercise patterns in young people with lung cancer.
View More
Osimertinib and Uncommon EGFR Mutations: Real-World Study Provides Insights
Jorge Nieva, MD
WCLC 2024
|
September 27, 2024
The real-world study was presented at the IASLC 2024 World Conference on Lung Cancer.
View More